These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28239820)

  • 1. Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway.
    Sun SJ; Lin Q; Ma JX; Shi WW; Yang B; Li F
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):504-510. PubMed ID: 28239820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HIF-2α-Dependent NEAT1 Promotes the Progression of Non-Small Cell Lung Cancer through miR-101-3p/SOX9/Wnt/β-Catenin Signal Pathway.
    Kong X; Zhao Y; Li X; Tao Z; Hou M; Ma H
    Cell Physiol Biochem; 2019; 52(3):368-381. PubMed ID: 30845377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
    Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
    Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits proliferation, migration and invasion of multiple myeloma cells via NEAT1-mediated Wnt/β-catenin signaling pathway.
    Geng W; Guo X; Zhang L; Ma Y; Wang L; Liu Z; Ji H; Xiong Y
    Biomed Pharmacother; 2018 Nov; 107():484-494. PubMed ID: 30107344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
    Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
    Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long non-coding RNA (lncRNA) cancer susceptibility candidate 2c (CASC2c) on proliferation, metastasis and drug resistance of non-small cell lung cancer (NSCLC) cells through ERK1/2 and β-catenin signaling pathways.
    Tong L; Wu W
    Pathol Res Pract; 2019 Sep; 215(9):152522. PubMed ID: 31300295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL‑21/IL‑21R inhibit tumor growth and invasion in non‑small cell lung cancer cells via suppressing Wnt/β‑catenin signaling and PD‑L1 expression.
    Xue D; Yang P; Wei Q; Li X; Lin L; Lin T
    Int J Mol Med; 2019 Nov; 44(5):1697-1706. PubMed ID: 31573051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues.
    Pan LJ; Zhong TF; Tang RX; Li P; Dang YW; Huang SN; Chen G
    Asian Pac J Cancer Prev; 2015; 16(7):2851-5. PubMed ID: 25854373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.
    Jiang P; Chen A; Wu X; Zhou M; Ul Haq I; Mariyam Z; Feng Q
    J Cell Physiol; 2018 Jun; 233(6):4852-4863. PubMed ID: 29152741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LINC00968 acts as oncogene in NSCLC by activating the Wnt signaling pathway.
    Wang Y; Zhou J; Xu YJ; Hu HB
    J Cell Physiol; 2018 Apr; 233(4):3397-3406. PubMed ID: 28926089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NEAT 1 knockdown enhances the sensitivity of human non-small-cell lung cancer cells to anlotinib.
    Gu G; Hu C; Hui K; Chen T; Zhang H; Jiang X
    Aging (Albany NY); 2021 May; 13(10):13941-13953. PubMed ID: 33982669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway.
    Luo Y; Chen JJ; Lv Q; Qin J; Huang YZ; Yu MH; Zhong M
    Cancer Lett; 2019 Jan; 440-441():11-22. PubMed ID: 30312725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.